To evaluate the Safety and efficacy of Unani formulations in the treatment of (Pustules/Boils)

Validation of Unani Pharmacopoeial formulations in Busoor-e-Jild (Pustules/Boils)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/01/004283

Enrollment

300

Registered

2014-01-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Busoor-e-Jild (Pustules/Boils) Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: 1. Majoon-e-Ushba 2.Arq Murakkab Musaffi Khoon : 1. Majoon-e-Ushba - 12gm orally daily 2.Arq Murakkab Musaffi Khoon - 25 ml orlly twice daily Both the agents are bei

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of 5 to 60 years. 2. Frequent occurrence of the following 3. Vesicles (a vesicle is a small blister, as on the skin. Vesicles are less than .5 centimeters in diameter) 4. Papules (Small solid rounded bumps rising from the skin that are each usually less than 1 centimeter in diameter (less than 3/8 inch across) 5. Pustules (Small solid rounded bumps rising from the skin that are each usually less than 1 centimeter in diameter (less than 3/8 inch across) 6. Macules (Flat , distinct, colored area of the skin less than 1 cm in diameter)

Exclusion criteria

Exclusion criteria: 1. Age 5 years and 60 years 2. Patients with diseases/ disorders requiring long term treatment 3. Patients with Diabetes mellitus 4. Patients with other inflammatory skin conditions like localized abscess/ carbuncles/ boils. 5. Pregnancy and Lactation

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptomsTimepoint: 6 WEEKS	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 6 WEEKS	—

Countries

India

Contacts

Public ContactDr Abdul Hannan

Central Council for Research in Unani Medicine (CCRUM),

ccrum605@gmail.com01128521981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026